Dominant-negative inhibition of Flk-1 suppresses the growth of many tumor types in vivo

Cancer Research

Volumn 56, Issue 7, 1996, Pages 1615-1620

  Millauer, Birgit ^a,e   Longhi, Michael P ^d   Plate, Karl H ^b   Shawver, Laura K ^d   Risau, Werner ^c   Ullrich, Axel ^a   Strawn, Laurie M ^d  

^a MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

^d SUGEN INC   (United States)

^e Pennie and Edmonds   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE; FIBROBLAST GROWTH FACTOR RECEPTOR; GROWTH FACTOR RECEPTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TUMOR; BREAST CARCINOMA; CANCER GROWTH; CONTROLLED STUDY; GLIOBLASTOMA; HUMAN; HUMAN CELL; LUNG CARCINOMA; MOUSE; NONHUMAN; OVARY CARCINOMA; PRIORITY JOURNAL; RAT; SOLID TUMOR; TUMOR VASCULARIZATION;

ANIMALS; ENDOTHELIAL GROWTH FACTORS; HUMANS; LYMPHOKINES; MICE; MICE, INBRED BALB C; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; RATS; RATS, INBRED F344; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, GROWTH FACTOR; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0029863730     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Folkman, J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med., 1: 27-31, 1995.
2. Ferrara, N Vascular endothelial growth factor. Trends Cardiovasc Med., 3: 244-250, 1993.
3. Plate, K. H., Breier, G , Weich, H. A , and Risau, W. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature (Lond.), 359: 845-848, 1992.
4. Shweiki, D., Itin, A., Soffer, D., and Keshet, E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature (Lond.), 359: 843-845, 1992.
5. Terman, B. I., Carrion, M. E., Kovacs, E., Rasmussen, B A., Eddy, R. L., and Shows, T B Identification of a new endothelial cell growth factor receptor tyrosine kinase. Oncogene, 6: 1677-1683, 1991
6. Millauer, B., Wizigmann-Voos, S., Schnürch, H., Martinez, R., Møller, N. P. H., Risau, W., and Ullrich, A. High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell, 72: 835-846, 1993
7. Peters, K. G., De Vries, C., and Williams, L. T Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth. Proc. Natl. Acad. Sci USA, 90: 8915-8919, 1993.
8. Millauer, B., Shawver, L. K , Plate, K. H., Risau, W , and Ullrich, A. Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature (Lond.), 367: 576-579, 1994
9. Plate, K. H., Breier, G., Millauer, B., Ullrich, A., and Risau, W. Up-regulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model of tumor angiogenesis. Cancer Res., 53: 5822-5827, 1993.
10. Shalaby, F., Rossant, J., Yamaguchi, T. P., Gertsenstein, M , Wu, X-F , Breitman, M. L., and Schuh, A. C. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice Nature (Lond.), 376: 62-66, 1995.
11. Strawn, L. M., Mann, E., Elliger, S. S., Chu, L. M , Germain, L L., Niederfellner, G , Ullrich, A., and Shawver, L. K. Inhibition of glioma cell growth by a truncated platelet-derived growth factor-β receptor. J Biol. Chem., 269: 21215-21222, 1994
12. Werner, S., Weinberg, W., Liao, X., Peters, K G., Blessing, M., Yuspa, S H., Weiner, R. L., and Williams, L T. Targeted expression of a dominant-negative FGF receptor mutant in the epidermis of transgenic mice reveals a role of FGF in keratinocyte organization and differentiation. EMBO J., 12: 2635-2643, 1993.
13. Werner, S., Smola, H., Liao, X., Longaker, M. T., Krieg, T., Hofschneider, P H., and Williams, L. T. The function of KGF in morphogenesis of epithelium and reepithelialization of wounds. Science (Washington DC), 266: 819-822, 1994.
14. Ueno, H., Colbert, H , Escobedo, J. A., and Williams, L. T. Inhibition of PDGF β receptor signal transduction by coexpression of a truncated receptor. Science (Washington DC), 252: 844-848, 1991.
15. Kashles, O., Yarden Y , Fischer, R , Ullrich A , and Schlessinger, J A dominant negative mutation suppresses the function of normal epidermal growth factor receptors by heterodimerization. Mol Cell Biol , 11 1454-1463, 1991
16. Redemann, N., Holzmann, B., von Ruden, T., Wagner, E. F., Schlessinger, J., and Ullrich, A. Anti-oncogenic activity of signalling-defective epidermal growth factor receptor mutants. Mol. Cell. Biol., 12: 491-498, 1992.
17. Kim, K. J , Li, B., Winer, J., Armanini, M., Gillett, N , Phillips, H S., and Ferrara, N. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature (Lond.), 362: 841-844, 1993.
18. Saleh, M., Stacker, S. A , and Wilks, A F. Inhibition of growth of C6 glioma cells in vivo by expression of antisense vascular endothelial growth factor sequence Cancer Res., 56: 393-401, 1996.
19. Connolly, D. T. Vascular permeability factor: a unique regulator of blood vessel function. J. Cell. Biochem., 47. 219-223, 1991
20. Plate, K. H., Breier, G., Weich, H. A., and Risau, W. Vascular endothelial growth factor and glioma angiogenesis coordinate induction of VEGF receptors, distribution of VEGF protein and possible in vivo regulatory mechanisms. Int. J. Cancer, 59: 520-529, 1994.
21. Senger, D. R., Van De Water, L., Brown, L. F , Nagy, J. A , Yeo, K-T., Yeo, T-K , Berse, B , Jackman, R. W., Dvorak, A. M., and Dvorak, H. F. Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer Metastasis Rev., 12: 303-324: 1993
22. Waltenberger, J., Claesson-Welsh, L., Siegbahn, A., Shibuya, M., and Heldin, C-H. Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. J. Biol. Chem , 269: 26988-26995, 1994.
23. Fong, G-H , Rossant, J , Gertsenstein, M., and Breitman, M. L. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium Nature (Lond.), 376: 66-70, 1995.
24. Dumont, D. J., Yamaguchi, T. P., Conlon, R. A., Rossant, J., and Breitman, M L. tek, a novel tyrosine kinase gene located on mouse chromosome 4, is expressed in endothelial cells and their presumptive precursors. Oncogene, 7: 1471-1480, 1992.
25. Mustonen, T., and Alitalo, K. Endothelial receptor tyrosine kinases involved in angiogenesis. J. Cell Biol., 129: 895-898, 1995
26. Sato, T. N., Tozawa, Y , Deutsch, U., Wolburg-Buchholz, K., Fujiwara, Y., Gendron-Maguire, M., Gridley, T , Wolburg, H., Risau, W., and Qin, Y Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature (Lond.), 376. 70-74, 1995.
27. Myoken, Y., Kayada, Y., Okamoto, T., Kan, M , Sato, G H , and Sato, J D Vascular endothelial cell growth factor (VEGF) produced by A-431 human epidermoid carcinoma cells and identification of VEGF membrane binding sites. Proc. Natl. Acad Sci. USA, 88: 5819-5823, 1991.
28. Connolly, D. T., Heuvelman, D. M., Nelson, R., Olander, J. V., Eppley, B. L., Delfino, J. J., Siegel, N. R., Leimgruber, R. M , and Feder, J. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J. Clin. Invest , 84: 1470-1478, 1989
29. Senger, D. R., Perruzzi, C. A., Feder, J , and Dvorak, H. F. A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines. Cancer Res., 46: 5629-5632, 1986